SynthesisFrontiers in immunology2024

Efficacy and safety of immune checkpoint inhibitors for EGFR mutated non-small cell lung cancer: a network meta-analysis.

Lin Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.